Activity of creatine kinase B subunit, as measured by an immunoinhibition assay,is persistently increased in certain healthy,asymptomatic adults,whose values for totalCK activity are within nomial limits. Serum samples from two such individuals were investigated by electrophoresis, heat inactivation, determination of activation energies, and immunosorption (on protein A). The results demonstrated the presence of a circulating complex of IgG and CK-BB, which has been described as macro CK, type I. To our knowledge, this is the first report of such macro CK isoenzymes in healthy individuals.
Materials and Methods
Total CK activity.
We determined total CK activity at 37 #{176}C by using Spin Chem CK-NAC Reagent (SmithKline Ave., Seattle, WA 98124. 'To whom correspondence should be directed.
Presented inpart at the 34th national meetingoftheAACC, Anaheim, CA, August 1982.
Received Feb. 4, 1983; accepted April 26,1983. 
CK isoenzymes.
The CK isoenzymes were from various sources.
For CK-MM, we used a serum sample from a healthy individual.
Serum from a patient with a confirmed acute myocardial infarction, drawn about 12 h after the event, was the source of CK-MB.
The source of CK-BB was human brain tissue. This was obtained at autopsy and homogenized in phosphate buffer (100 mmol/L, pH 7.4, containing 10 mmol of mercaptoethanol per liter), then clarified by ultracentrifugation (4 #{176}C) and filtration (0.2 m, av pore size); after the protein concentration was adjusted to 50 g/L by adding lyophilized bovine serum albumin (Sigma Chemical Co., St. Louis, MO 63178; cat. no. A-4503), the preparation was stored at -70#{176}C.
Mitochondrial CK (CK-Mt) was from cardiac tissue obmined at autopsy. The tissue was homogenized in Ti-is buffer(50 mmol plus 100 mmol ofNaC1 per liter, pH 8.0), clarified by ultracentrifugation and filtration, and separated on a DEAE Sephadex A-50 column according to Mercer (7) . A portion of Fraction I (CK-Mt and CK-MM) was frozen (-20 #{176}C) and thawed twice, then allowed to stand at room temperature for 8 h. tiate these two groups by their response to heating. One of a set of duplicatesamples of CK-Mt, CK-MM, CK-MB, CK-BB, and serum samples from the affected individuals was held at 4 #{176}C while the other set was incubated at 45 #{176}C for 20 mm, then quickly cooled to room temperature. The paired samples, except those containing CK-MM, were assayed in duplicate by immunoinhibition.
The stability of CK-MM was determined by using the total CK procedure as described above. Activation energies. The activation energies of most serum enzymes, including the MM, MB, and BB isoenzymes of CK, as well as the variant IgG:CK-BB, range from 40 to 65 kJ/ mol of substrate. The activation energy for the variant CKMt, however, is greater than 80 kJ/mol of substrate (6) . These wide differences in activation energies may be exploited to differentiate the variant isoenzymes of CK.
Using the immunoinhibition assay on the Abbott VP, we assayed at 25,30,and 37 #{176}C sera from affected individuals and samples containing CK-Mt, CK-MB, and CK-BB. A sample containing CK-MM was similarly assayed by the total CK procedure.
The activity observed at each temperature was converted to its natural log (y-axis) and plotted vs 1/T (Kelvin) X 1000 (x-axis). The slope (b) was calculated from regression analysisand multiplied by the gas constant to yield the activation energy: Ea = -8.31 x b.
Immunosorption.
Protein A from Staphylococcus aureus, 
Results
We statistically analyzed the CK-B subunit activity as measured by immunoinhibition assay in each of our 78
healthy volunteers. Figure 1 shows the computer-generated histogram and distribution curve for these data, illustrating the three outliers with increased CK-B subunit activity.
Two of the persons represented by these outliers have been available for further study and have continued to demon- strate this supranormal CK-B subunit activity, which, in fact, has slightly increased (from 14 to 19 ± 1.0 U/L and from 12 to 18 ± 1.0 U/L) during the succeeding 14 months. Electrophoretic separation of the CK isoenzymes ( Figure  2 ) revealed two bands of CK activity for the affected individuals.
One band corresponded in mobility to that of CK-MM in the marker, the second band migrating anodically, with a mobility between that of CK-MM and CK-MB.
The CK-B subunit activity in the affected individuals demonstrated good thermal stability (Table 1) The similarities between the properties of the material responsible for the persistent CK-B subunit activity we have observed in our subjects and those described by others (9,12) make us confident that our subjects, even though healthy, are also demonstrating an autoimmune response to CK-BB. Using the presence of a CK band migrating between CK-MM and CK-MB in a routine electrophoretic screen for CK-MB as a criterion for IgG:CK-BB, we found an incidence of 0.8% (13 of 1686) of IgG:CK-BB in patients hospitalized with the presumptive diagnosis of acute myocardial infarction. Lang and Wurzburg estimated in a recent review (11) that 3 to 6% of all hospitalized patients demonstrate a macromolecular form of CK when the immunoinhibition technique is used. For the subset of patients with suspected acute myocardmal infarction, the incidence of macromolecular CK drops to about 0.5% if patients with normal values In our immunoinhibition study of healthy l/T 1 nonhospitalized subjects, we found an incidence of 3.8% (three of 78) of macromolecular CK and confirmed that two of them had circulating IgG:CK-BB. Insufficient sample was available to characterize the isoenzyme in the third subject.
In our group of 13 hospitalizedpatients with electrophoretic evidence of IgG:CK-BB, 10 had discharge diagnoses of heart disease, one of stroke, one rheumatoid arthritis, and one was discharged without a diagnosis. Our experience is consistent with that of others, showing a predominance of cardiac symptoms, probably owing to the patient selection process. Additional disease states presenting with IgG:CK-BB have included gastric carcinoma, prostatic carcinoma, thyrotoxicosis, pulmonary hypertension, and diabetes with no distinct correlation (4, 9, 11-13). IgG:CK-BB appears predominantly in women. Our hospitalized patient study showed a 10-fold increase in prevalence in women. In addition, the mean activity of the complex was greater for women (110 U/L) than for men (20 U/L), as determined by densitometry.
Our study on 78 healthy individuals detected two IgG:CK-BB complexes with a possibility of a third. All three were women, ages 24, 39, and 54. The reported too predominance of such complexes of CK in women older than 50 years (11) may be a concentration-related finding; more sensitive tests for IgG:CK-BB may detect these complexes in a younger population. The prevalence in women may be a nonspecific finding ascribable to sex-related differences in types of circulating immune complexes.
Alternatively, the original antigen in females may be CK-BB from the myometrium of the uterus, because this tissue is relatively rich in CK-BB (15) and is open to the peripheral circulatory system during menses. We did not find a correlation between the amount of IgG:CK-BB and the menstrual cycle. If this is indeed the mechanism of the autoimmune response in females, the initial stimulus would be expected to occur after pubescence.
Therefore, it will be of great interest to us if this macromolecular complex is found in preadolescents.
We must point out, however, that there are many possible sources for CK-BB, such as the gastrointestinal tract and smooth muscle. The observation of IgG:CK-BB in healthy, asymptomatic individuals as well as hospitalized subjects of relatively advanced years would seem to indicate that this is a benign phenomenon, not indicative of any particular disease process. 
Discussion
The persistently increased CK-B subunit activity that we have observed in healthy, asymptomatic individuals is characterizedby an electrophoretic mobility between CK-MM and CK-MB, relatively high thermal stability, relatively low activation energy (as compared with CK-Mt), and binding by protein A (S. aureus). One or several of these characteristics have been ascribed by various investigators to a circulating complex between IgG and CK-BB (6, 8-11) . We have not directly differentiated whether this complex is a nonspecific protein-protein interaction or a specific antigen-antibody reaction, but others have demonstrated in certain patients that the criteria for an immune (antigenantibody) complex have been satisfied: CK-BB is the specific antigen (little or no cross reactivity with CK-MM or CK-
